Full Name
Koh Chee Liang, Stephen
(not current staff)
Variants
Koh, S.C.L.
Kohsc, L.
Kohcl, S.
Koh, C.L.S.
Koh, C.S.
Koh, S.C.
Koh, S.
 
Main Affiliation
 
 
Email
obgkohcl@nus.edu.sg
 

Publications

Refined By:
Date Issued:  [2000 TO 2009]

Results 1-13 of 13 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
12006A prognosis tool based on hemostasis and genetic complementary learningTan, T.Z.; Ng, G.S.; Quek, C.; Koh, S.C.L. 
22000An assessment of the effects on coagulation of midtrimester and final- trimester amniotic fluid on whole blood by thrombelastograph® analysisLiu, E.H.C. ; Shailaja, S.; Lee, T.-L. ; Koh, S.C.L. 
32005An intelligent tutoring system for trauma management (Trauma-Teach): A preliminary reportOng, L.S. ; Koh, C.S. ; Lai, C.C.; Lim, C.W. ; Loke, W.F.; Low, S.H. ; Tang, K.Y.; Wong, F.L.; Yong, K.L.; Vijayan, A.
42007Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancerZhao, C.; Annamalai, L. ; Koh, S.C.L. ; Zhang, H.; Biswas, A. ; Choolani, M. ; Guo, C.; Kothandaraman, N. 
52005Coagulation and fibrinolysis in preeclampsia and neonatesTanjung, M.T.; Siddik, H.D.; Hariman, H.; Koh, S.C.L. 
62004Early detection of epithelial ovarian cancer using a proteomics-based protein-profiling approach combined with a novel selection strategy.Kothandaraman, N.; Bajic, V.B.; Loganath, A. ; Koh, S. ; Ng, J.; Choolani, M. ; Razvi, K.
72000Enhanced fibrinolysis and thrombin generation in ovarian cancer patients with than without metastasisKohcl, S. ; Thamk, F. ; Khalil, R. ; Oep, L.; Lim, F.K. ; Chua, S.E.; Yuen, W.K.; Ng, B.L.; Roy, A.C. ; Prasad, R.N.V. 
82001Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?Koh, S.C.L. ; Tham, K.-F. ; Razvi, K. ; Oei, P.-L. ; Lim, F.-K. ; Roy, A.-C. ; Prasad, R.N.V. 
92001Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?Koh, S.C.L. ; Tham, K.-F. ; Razvi, K.; Oei, P.-L. ; Lim, F.-K. ; Roy, A.-C. ; Prasad, R.N.V. 
10Jul-2005Hemostatic status and fibrinolytic response potential at different phases of the menstrual cycleKoh, S.C.L. ; Prasad, R.N.V. ; Fong, Y.F. 
112005Hemostatic status and fibrinolytic response potential at different phases of the menstrual cycleKoh, S.C.L. ; Prasad, R.N.V. ; Fong, Y.F. 
122006The association between fibrinogen, von Willebrand Factor, antithrombin III, and D-dimer levels and survival outcome by 36 months from ovarian cancerKoh, S.C.L. ; Khalil, R.; Lim, F.-K.; Ilancheran, A. ; Choolani, M. 
132007The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic/inhibitor systems in women with menorrhagiaKoh, S.C.L. ; Singh, K.